Patents by Inventor Ayumi Fujisawa

Ayumi Fujisawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTIVALENT RECOMBINANT AVIAN HERPES VIRUSES AND VACCINES FOR IMMUNIZING AVIAN SPECIES
    Publication number: 20240082390
    Abstract: The present invention relates to a recombinant avian herpes virus, which comprises at least two recombinant nucleotide sequences, each recombinant nucleotide sequence encoding a distinct antigenic peptide, wherein the at least two recombinant nucleotide sequences are inserted into distinct non-coding regions of the viral genome chosen among the region located between UL44 and UL45, the region located between UL45 and UL46, the region located between US10 and SORF3, and the region located between SORF3 and US2.
    Type: Application
    Filed: August 21, 2023
    Publication date: March 14, 2024
    Inventors: AYUMI FUJISAWA, MAYUMI KUBOMURA, SAKIKO SAEKI, SHUJI SAITO
  • Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
    Patent number: 11730807
    Abstract: The present invention relates to a recombinant avian herpes virus, which comprises at least two recombinant nucleotide sequences, each recombinant nucleotide sequence encoding a distinct antigenic peptide, wherein the at least two recombinant nucleotide sequences are inserted into distinct non-coding regions of the viral genome chosen among the region located between UL44 and UL45, the region located between UL45 and UL46, the region located between US10 and SORF3, and the region located between SORF3 and US2.
    Type: Grant
    Filed: September 15, 2021
    Date of Patent: August 22, 2023
    Assignee: CEVA SANTE ANIMALE
    Inventors: Ayumi Fujisawa, Mayumi Kubomura, Sakiko Saeki, Shuji Saito
  • RECOMBINANT AVIAN HERPES VIRUSES CONTAINING MULTIPLE FOREIGN GENES
    Publication number: 20220040287
    Abstract: The present invention relates to recombinant avian herpes viruses containing multiple genes inserted into separate intergenic regions, their manufacture, compositions comprising the same, and the uses thereof.
    Type: Application
    Filed: December 20, 2019
    Publication date: February 10, 2022
    Inventor: Ayumi Fujisawa
  • MULTIVALENT RECOMBINANT AVIAN HERPES VIRUSES AND VACCINES FOR IMMUNIZING AVIAN SPECIES
    Publication number: 20210401973
    Abstract: The present invention relates to a recombinant avian herpes virus, which comprises at least two recombinant nucleotide sequences, each recombinant nucleotide sequence encoding a distinct antigenic peptide, wherein the at least two recombinant nucleotide sequences are inserted into distinct non-coding regions of the viral genome chosen among the region located between UL44 and UL45, the region located between UL45 and UL46, the region located between US10 and SORF3, and the region located between SORF3 and US2.
    Type: Application
    Filed: September 15, 2021
    Publication date: December 30, 2021
    Inventors: AYUMI FUJISAWA, MAYUMI KUBOMURA, SAKIKO SAEKI, SHUJI SAITO
  • Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
    Patent number: 11123425
    Abstract: The present invention relates to a recombinant avian herpes virus, which comprises at least two recombinant nucleotide sequences, each recombinant nucleotide sequence encoding a distinct antigenic peptide, wherein the at least two recombinant nucleotide sequences are inserted into distinct non-coding regions of the viral genome chosen among the region located between UL44 and UL45, the region located between UL45 and UL46, the region located between US10 and SORF3, and the region located between SORF3 and US2.
    Type: Grant
    Filed: December 9, 2019
    Date of Patent: September 21, 2021
    Assignee: CEVA SANTE ANIMALE
    Inventors: Ayumi Fujisawa, Mayumi Kubomura, Sakiko Saeki, Shuji Saito
  • MULTIVALENT RECOMBINANT AVIAN HERPES VIRUSES AND VACCINES FOR IMMUNIZING AVIAN SPECIES
    Publication number: 20200108137
    Abstract: The present invention relates to a recombinant avian herpes virus, which comprises at least two recombinant nucleotide sequences, each recombinant nucleotide sequence encoding a distinct antigenic peptide, wherein the at least two recombinant nucleotide sequences are inserted into distinct non-coding regions of the viral genome chosen among the region located between UL44 and UL45, the region located between UL45 and UL46, the region located between US10 and SORF3, and the region located between SORF3 and US2.
    Type: Application
    Filed: December 9, 2019
    Publication date: April 9, 2020
    Inventors: AYUMI FUJISAWA, MAYUMI KUBOMURA, SAKIKO SAEKI, SHUJI SAITO
  • Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
    Patent number: 10500270
    Abstract: The present invention relates to a recombinant avian herpes virus, which comprises at least two recombinant nucleotide sequences, each recombinant nucleotide sequence encoding a distinct antigenic peptide, wherein the at least two recombinant nucleotide sequences are inserted into distinct non-coding regions of the viral genome chosen among the region located between UL44 and UL45, the region located between UL45 and UL46, the region located between US10 and SORF3, and the region located between SORF3 and US2.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: December 10, 2019
    Assignee: CEVA SANTE ANIMALE
    Inventors: Ayumi Fujisawa, Mayumi Kubomura, Sakiko Saeki, Shuji Saito
  • Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
    Patent number: 10251951
    Abstract: The present invention relates to a recombinant avian herpes virus, which comprises at least two recombinant nucleotide sequences, each recombinant nucleotide sequence encoding a distinct antigenic peptide, wherein the at least two recombinant nucleotide sequences are inserted into distinct non-coding regions of the viral genome chosen among the region located between UL44 and UL45, the region located between UL45 and UL46, the region located between US10 and SORF3, and the region located between SORF3 and US2.
    Type: Grant
    Filed: March 29, 2013
    Date of Patent: April 9, 2019
    Assignee: CEVA SANTA ANIMALE
    Inventors: Ayumi Fujisawa, Mayumi Kubomura, Sakiko Saeki, Shuji Saito
  • Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
    Patent number: 10245315
    Abstract: The present invention relates to a recombinant avian herpes virus, which comprises at least two recombinant nucleotide sequences, each recombinant nucleotide sequence encoding a distinct antigenic peptide, wherein the at least two recombinant nucleotide sequences are inserted into distinct non-coding regions of the viral genome chosen among the region located between UL44 and UL45, the region located between UL45 and UL46, the region located between US10 and SORF3, and the region located between SORF3 and US2.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: April 2, 2019
    Assignee: CEVA SANTE ANIMALE
    Inventors: Ayumi Fujisawa, Mayumi Kubomura, Sakiko Saeki, Shuji Saito
  • MULTIVALENT RECOMBINANT AVIAN HERPES VIRUSES AND VACCINES FOR IMMUNIZING AVIAN SPECIES
    Publication number: 20180256707
    Abstract: The present invention relates to a recombinant avian herpes virus, which comprises at least two recombinant nucleotide sequences, each recombinant nucleotide sequence encoding a distinct antigenic peptide, wherein the at least two recombinant nucleotide sequences are inserted into distinct non-coding regions of the viral genome chosen among the region located between UL44 and UL45, the region located between UL45 and UL46, the region located between US10 and SORF3, and the region located between SORF3 and US2.
    Type: Application
    Filed: May 7, 2018
    Publication date: September 13, 2018
    Inventors: Ayumi Fujisawa, Mayumi Kubomura, Sakiko Saeki, Shuji Saito
  • MULTIVALENT RECOMBINANT AVIAN HERPES VIRUSES AND VACCINES FOR IMMUNIZING AVIAN SPECIES
    Publication number: 20180256706
    Abstract: The present invention relates to a recombinant avian herpes virus, which comprises at least two recombinant nucleotide sequences, each recombinant nucleotide sequence encoding a distinct antigenic peptide, wherein the at least two recombinant nucleotide sequences are inserted into distinct non-coding regions of the viral genome chosen among the region located between UL44 and UL45, the region located between UL45 and UL46, the region located between US10 and SORF3, and the region located between SORF3 and US2.
    Type: Application
    Filed: May 7, 2018
    Publication date: September 13, 2018
    Inventors: AYUMI FUJISAWA, MAYUMI KUBOMURA, SAKIKO SAEKI, SHUJI SAITO
  • MULTIVALENT RECOMBINANT AVIAN HERPES VIRUSES AND VACCINES FOR IMMUNIZING AVIAN SPECIES
    Publication number: 20150118250
    Abstract: The present invention relates to a recombinant avian herpes virus, which comprises at least two recombinant nucleotide sequences, each recombinant nucleotide sequence encoding a distinct antigenic peptide, wherein said at least two recombinant nucleotide sequences are inserted into distinct non-coding region of the viral genome chosen among the region located between UL44 and UL45, the region located between UL45 and UL46, the region located between US10 and SORF3, the region located between SORF3 and US2.
    Type: Application
    Filed: March 29, 2013
    Publication date: April 30, 2015
    Inventors: Ayumi Fujisawa, Mayumi Kubomura, Sakiko Saeki, Shuji Saito
  • Poultry mycoplasma antigen, gene thereof and recombinant vectors containing the gene as well as vaccines utilizing the same
    Patent number: 5489430
    Abstract: A highly effective vaccine for Mycoplasma gallisepticum infection utilizing a substantially pure protein capable of reacting with Mycoplasma gallisepticum immunized serum or Mycoplasma gallisepticum infected serum, having a molecular weight of about 40 kilodaltons encoded by DNA sequence derived from Mycoplasma gallisepticum and having a specific restriction enzyme map, or a protein functionally equivalent thereto.
    Type: Grant
    Filed: January 25, 1994
    Date of Patent: February 6, 1996
    Assignees: Nippon Zeon Co., Ltd., Shionogi & Co., Ltd.
    Inventors: Shuji Saito, Setsuko Ohkawa, Ayumi Fujisawa, Yoshikazu Iritani, Shigemi Aoyama